Legal & General Group
ANGO icon

Legal & General Group’s AngioDynamics ANGO Stock Holding History

Legal & General Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Sell
12,178
-100
-0.8% -$1.08K ﹤0.01% 2578
2025
Q4 		$158K Sell
12,278
-75
-0.6% -$926 ﹤0.01% 2601
2025
Q3 		$138K Hold
12,353
– – ﹤0.01% 2614
2025
Q2 		$123K Buy
12,353
+9,098
+280% +$89.1K ﹤0.01% 2629
2025
Q1 		$30.6K Hold
3,255
– – ﹤0.01% 2808
2024
Q4 		$29.8K Hold
3,255
– – ﹤0.01% 2887
2024
Q3 		$25.3K Hold
3,255
– – ﹤0.01% 2954
2024
Q2 		$19.7K Hold
3,255
– – ﹤0.01% 3022
2024
Q1 		$19.1K Sell
3,255
-1,810
-36% -$10.8K ﹤0.01% 2984
2023
Q4 		$39.7K Sell
5,065
-26,835
-84% -$186K ﹤0.01% 2839
2023
Q3 		$233K Sell
31,900
-75,416
-70% -$627K ﹤0.01% 2686
2023
Q2 		$1.12M Buy
107,316
+12,128
+13% +$117K ﹤0.01% 2175
2023
Q1 		$984K Sell
95,188
-1,192
-1% -$15.3K ﹤0.01% 2157
2022
Q4 		$1.33M Buy
96,380
+2,626
+3% +$36.5K ﹤0.01% 2062
2022
Q3 		$1.92M Buy
93,754
+652
+0.7% +$14.3K ﹤0.01% 1870
2022
Q2 		$1.8M Buy
93,102
+851
+0.9% +$17.4K ﹤0.01% 1942
2022
Q1 		$1.99M Sell
92,251
-801
-0.9% -$18.2K ﹤0.01% 1984
2021
Q4 		$2.57M Buy
93,052
+3,526
+4% +$97.3K ﹤0.01% 1914
2021
Q3 		$2.32M Buy
89,526
+7,967
+10% +$213K ﹤0.01% 1954
2021
Q2 		$2.21M Sell
81,559
-25,065
-24% -$612K ﹤0.01% 1922
2021
Q1 		$2.49M Buy
106,624
+1,266
+1% +$25.6K ﹤0.01% 1884
2020
Q4 		$1.61M Sell
105,358
-477
-0.5% -$6.05K ﹤0.01% 1975
2020
Q3 		$1.28M Buy
105,835
+773
+0.7% +$7.34K ﹤0.01% 1949
2020
Q2 		$1.07M Buy
105,062
+8,399
+9% +$86.6K ﹤0.01% 1961
2020
Q1 		$1.01M Buy
96,663
+11
+0% +$138 ﹤0.01% 1845
2019
Q4 		$1.55M Buy
96,652
+5,913
+7% +$90.3K ﹤0.01% 1913
2019
Q3 		$1.67M Buy
90,739
+2,851
+3% +$55.8K ﹤0.01% 1797
2019
Q2 		$1.73M Buy
87,888
+62
+0.1% +$1.26K ﹤0.01% 1757
2019
Q1 		$2.01M Buy
87,826
+8,294
+10% +$180K ﹤0.01% 1701
2018
Q4 		$1.6M Sell
79,532
-111
-0.1% -$2.3K ﹤0.01% 1694
2018
Q3 		$1.73M Buy
79,643
+7,184
+10% +$160K ﹤0.01% 1758
2018
Q2 		$1.61M Buy
72,459
+3,707
+5% +$75.8K ﹤0.01% 1759
2018
Q1 		$1.18M Buy
68,752
+1,902
+3% +$31.7K ﹤0.01% 1841
2017
Q4 		$1.11M Buy
66,850
+1,293
+2% +$22.1K ﹤0.01% 1852
2017
Q3 		$1.12M Buy
65,557
+4,296
+7% +$72.2K ﹤0.01% 1821
2017
Q2 		$993K Buy
61,261
+8,860
+17% +$140K ﹤0.01% 1832
2017
Q1 		$910K Buy
52,401
+1,117
+2% +$18.7K ﹤0.01% 1833
2016
Q4 		$865K Buy
51,284
+27,779
+118% +$463K ﹤0.01% 1795
2016
Q3 		$410K Buy
23,505
+19,784
+532% +$321K ﹤0.01% 1797
2016
Q2 		$52K Hold
3,721
– – ﹤0.01% 2457
2016
Q1 		$45K Hold
3,721
– – ﹤0.01% 2459
2015
Q4 		$45K Hold
3,721
– – ﹤0.01% 2504
2015
Q3 		$49K Hold
3,721
– – ﹤0.01% 2457
2015
Q2 		$61K Hold
3,721
– – ﹤0.01% 2445
2015
Q1 		$66K Hold
3,721
– – ﹤0.01% 2329
2014
Q4 		$71K Hold
3,721
– – ﹤0.01% 2227
2014
Q3 		$51K Buy
+3,721
New +$53.1K ﹤0.01% 2367

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Legal & General Group's ANGO Position: Q1 2026 in Review

Legal & General Group reduced its AngioDynamics (ANGO) stake by 0.81% in Q1 2026, selling an estimated $1.08K and leaving 12,178 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

Legal & General Group first reported a position in ANGO in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.57M in Q4 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Legal & General Group held 12,178 shares of AngioDynamics worth $138K as of Q1 2026.
  • Legal & General Group sold 100 AngioDynamics shares in Q1 2026, an estimated $1.08K.
  • AngioDynamics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2578 holding.
  • Legal & General Group first reported a position in AngioDynamics in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's AngioDynamics position peaked at $2.57M in Q4 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.